Jacobs Levy Equity Management, Inc Tg Therapeutics, Inc. Transaction History

Jacobs Levy Equity Management, Inc

  • $25.8 Billion
  • Q4 2024

A detailed history of Jacobs Levy Equity Management, Inc transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 84,589 shares of TGTX stock, worth $3.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
84,589
Previous 180,338 53.09%
Holding current value
$3.4 Million
Previous $4.22 Million 39.64%
% of portfolio
0.01%
Previous 0.02%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$21.31 - $35.09 $2.04 Million - $3.36 Million
-95,749 Reduced 53.09%
84,589 $2.55 Million
Q2 2024

Aug 14, 2024
SELL
$13.32 - $19.19 $4.59 Million - $6.61 Million
-344,523 Reduced 65.64%
180,338 $3.21 Million
Q1 2024

May 15, 2024
BUY
$13.02 - $21.3 $1.57 Million - $2.57 Million
120,699 Added 29.86%
524,861 $7.98 Million
Q4 2023

Feb 14, 2024
SELL
$6.68 - $18.81 $9,726 - $27,387
-1,456 Reduced 0.36%
404,162 $6.9 Million
Q3 2023

Nov 16, 2023
BUY
$8.36 - $26.5 $1.22 Million - $3.86 Million
145,667 Added 56.04%
405,618 $3.39 Million
Q1 2023

May 15, 2023
SELL
$10.23 - $19.34 $1.1 Million - $2.08 Million
-107,522 Reduced 29.26%
259,951 $3.91 Million
Q4 2022

Feb 14, 2023
BUY
$5.01 - $11.83 $1.28 Million - $3.02 Million
254,978 Added 226.66%
367,473 $4.35 Million
Q3 2022

Nov 15, 2022
BUY
$4.57 - $8.4 $514,102 - $944,958
112,495 New
112,495 $666,000
Q3 2020

Nov 16, 2020
SELL
$18.49 - $27.24 $441,910 - $651,036
-23,900 Closed
0 $0
Q2 2020

Aug 17, 2020
SELL
$8.9 - $21.84 $13,358 - $32,781
-1,501 Reduced 5.91%
23,900 $466,000
Q1 2020

May 15, 2020
SELL
$7.14 - $15.99 $1.03 Million - $2.3 Million
-143,799 Reduced 84.99%
25,401 $250,000
Q4 2019

Feb 14, 2020
BUY
$5.1 - $11.2 $248,879 - $546,560
48,800 Added 40.53%
169,200 $1.88 Million
Q3 2019

Nov 14, 2019
BUY
$5.38 - $8.99 $66,712 - $111,476
12,400 Added 11.48%
120,400 $676,000
Q2 2019

Aug 13, 2019
BUY
$6.27 - $8.65 $677,160 - $934,200
108,000 New
108,000 $934,000
Q3 2018

Nov 14, 2018
SELL
$5.15 - $14.0 $137,556 - $373,940
-26,710 Closed
0 $0
Q2 2018

Aug 14, 2018
BUY
$12.5 - $15.0 $333,875 - $400,650
26,710 New
26,710 $351,000

Others Institutions Holding TGTX

# of Institutions
372
Shares Held
85.5M
Call Options Held
3.78M
Put Options Held
3M
View Full List

About TG THERAPEUTICS, INC.

TGTX Quotes by TradingView
  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $5.84B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Jacobs Levy Equity Management, Inc Portfolio

Follow Jacobs Levy Equity Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email